BL
MGRX icon

BFSG LLC’s Mangoceuticals MGRX Stock Holding History

BFSG LLC’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13
Closed -$44 – 656
2024
Q1 		$44 Buy
+13
New +$52 ﹤0.01% 654

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFSG LLC's MGRX Position: Q2 2024 in Review

BFSG LLC sold out of Mangoceuticals (MGRX) in Q2 2024, closing a stake of 13 shares — an estimated $44 sold.

BFSG LLC first reported a position in MGRX in Q1 2024 and held it in 1 quarter. The position peaked at $44 in Q1 2024. 6 funds tracked by Wall St. Rank hold MGRX as of Q2 2024.

  • BFSG LLC reported no remaining Mangoceuticals position as of Q2 2024 after selling out during the quarter.
  • BFSG LLC sold 13 Mangoceuticals shares in Q2 2024, an estimated $44.
  • BFSG LLC first reported a position in Mangoceuticals in Q1 2024 and held it in 1 quarter.
  • BFSG LLC's Mangoceuticals position peaked at $44 in Q1 2024.
  • 6 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2024.

Based on BFSG LLC's 13F filing for Q2 2024, filed 29 Jul 2024.